leukemia

Showing NaN - NaN of 113

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

People Living With HIV Treated With CD19-directed CAR T Cell

Active, not recruiting
  • Leukemia
  • +9 more
    • Philadelphia, Pennsylvania
      Pennsylvania Hospital
    Mar 29, 2023

    Leukemia, Lymphoma, Cardiotoxicity Trial in Philadelphia

    Completed
    • Leukemia
    • +4 more
      • Philadelphia, Pennsylvania
        Abramson Cancer Center of the University of Pennsylvania
      Jan 19, 2023

      Bone Marrow Cancer, Leukemia, Lymphoma Trial in Philadelphia (Virtual reality, Environmental changes)

      Enrolling by invitation
      • Bone Marrow Cancer
      • +4 more
      • Virtual reality
      • Environmental changes
      • Philadelphia, Pennsylvania
        Thomas Jefferson University Hospital
      Jan 9, 2023

      Leukemia Trial in United States (mercaptopurine, methotrexate, tretinoin)

      Completed
      • Leukemia
      • Scottsdale, Arizona
      • +209 more
      Dec 14, 2022

      Leukemia Trial in United States (arsenic trioxide, gemtuzumab ozogamicin, mercaptopurine)

      Completed
      • Leukemia
      • arsenic trioxide
      • +4 more
      • Roseville, California
      • +191 more
      Dec 14, 2022

      Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

      Recruiting
      • Clinical Stage I Cutaneous Melanoma AJCC v8
      • +33 more
      • Informational Intervention
      • +4 more
      • Los Angeles, California
      • +4 more
      Dec 14, 2022

      Leukemia Trial in Worldwide (Dasatinib)

      Active, not recruiting
      • Leukemia
      • Birmingham, Alabama
      • +173 more
      Dec 1, 2022

      Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)

      Active, not recruiting
      • Hematopoietic and Lymphoid System Neoplasm
      • +3 more
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • +3 more
      • Birmingham, Alabama
      • +42 more
      Jul 20, 2022

      Leukemia, Brain Tumor, Solid Tumor Trial in United States (ALRN-6924, Cytarabine)

      Recruiting
      • Leukemia
      • +3 more
      • San Francisco, California
      • +3 more
      Jun 14, 2022

      Leukemia Trial in France, United States (BAY2402234)

      Terminated
      • Leukemia
      • Bronx, New York
      • +4 more
      Dec 20, 2021

      Leukemia, Inborn Errors of Metabolism, Bone Marrow Failure Syndromes Trial in Philadelphia (Transplant of stem cells with

      Recruiting
      • Leukemia
      • +4 more
      • Transplant of stem cells with CD3+/CD19+ depletion (CliniMACs)
      • Philadelphia, Pennsylvania
        Children's Hospital of Philadelphia
      Nov 2, 2021

      Leukemia, Bone Marrow Failure Syndrome, Immunodeficiencies Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using

      Available
      • Leukemia
      • +2 more
      • Apha/beta T and CD19+ cell depletion using CliniMACS device
      • Philadelphia, Pennsylvania
        Children's Hospital of Philadelphia
      Nov 2, 2021

      Leukemia, Lymphoma, Myelodysplasia Trial in Philadelphia (Alpha Beta T cell depletion)

      Recruiting
      • Leukemia
      • +2 more
      • Alpha Beta T cell depletion
      • Philadelphia, Pennsylvania
        The Children's Hospital of Philadelphia
      Oct 27, 2021

      Leukemia Trial in Canada, United States (troxacitabine)

      Completed
      • Leukemia
      • Duarte, California
      • +19 more
      Jun 7, 2021

      Leukemia Trial in Worldwide (asparaginase, cytarabine, daunorubicin HCl)

      Completed
      • Leukemia
      • Birmingham, Alabama
      • +197 more
      Mar 22, 2021

      Leukemia Trial in Israel, United States (biological, drug, procedure)

      Completed
      • Leukemia
      • sargramostim
      • +7 more
      • Birmingham, Alabama
      • +98 more
      Oct 23, 2020

      Breast Carcinoma, Cancer Survivor, Depression Trial in United States (procedure, other, behavioral)

      Completed
      • Breast Carcinoma
      • +12 more
      • Management of Therapy Complications
      • +3 more
      • Los Angeles, California
      • +5 more
      Oct 8, 2020

      Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit, Cleveland, Philadelphia (educational

      Completed
      • Brain and Central Nervous System Tumors
      • +8 more
      • educational intervention
      • Detroit, Michigan
      • +3 more
      Jul 23, 2020

      Leukemia Trial in Canada, United States (rituximab, fludarabine phosphate)

      Terminated
      • Leukemia
      • rituximab
      • fludarabine phosphate
      • Anniston, Alabama
      • +386 more
      Apr 9, 2020

      Leukemia Trial in Philadelphia (Interferon alpha-2B (IFN-a) 3 million units (MU) subcutaneous daily)

      Completed
      • Leukemia
      • Interferon alpha-2B (IFN-α) 3 million units (MU) subcutaneous daily
      • Philadelphia, Pennsylvania
        Abramson Cancer Center of the University of Pennsylvania
      Apr 20, 2020

      Leukemia Trial in Canada, United States (biological, drug, other, procedure)

      Completed
      • Leukemia
      • anti-thymocyte globulin
      • +10 more
      • Birmingham, Alabama
      • +51 more
      Apr 7, 2020

      Leukemia, Lymphoma Trial in Canada, United States (biological, drug, procedure, radiation)

      Terminated
      • Leukemia
      • Lymphoma
      • therapeutic allogeneic lymphocytes
      • +8 more
      • Denver, Colorado
      • +22 more
      Apr 8, 2020

      Hematological Malignancies, Leukemia, Lymphoma Trial in Philadelphia (Matched Sibling Allogeneic Transplantation)

      Completed
      • Hematological Malignancies
      • +4 more
      • Matched Sibling Allogeneic Transplantation
      • Philadelphia, Pennsylvania
        Thomas Jefferson University
      Sep 27, 2019